Educational — Not Legal AdviceReviewed
Is PT-141 legal? FDA status and US regulatory standing
Current status
FDA-approved. PT-141 is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
PT-141 is an FDA-approved drug. FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
Also known as
Bremelanotide · Vyleesi
Status history
- PT-141 is an FDA-approved drug. [source]
Frequently asked questions
- Is PT-141 FDA approved?
- PT-141 is an FDA-approved drug (status recorded 2019-06-21). Primary source linked on this page.
- Can doctors prescribe PT-141?
- PT-141 is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .